Literature DB >> 21744265

Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population.

Neha Singh1, Nakul Sinha, Sudeep Kumar, Chandra M Pandey, Suraksha Agrawal.   

Abstract

Chemokines regulates the trafficking of leukocytes to the site of inflammation hence may be implicated in cardiac events. Currently no consistent effects have been revealed their role in acute myocardial infarction (MI). The aim of current study was to investigate the impact of human chemokine receptor genetic variants, CCR5-Δ32 insertion/deletion, CCR5-59029-A/G, CX3CR1-V249I and CX3CR1-T280 M on acute MI. 230 acute MI and 300 controls were examined. Patients carrying CCR5-Δ32 genotype were at three times higher risk of developing MI odds ratio (OR, 3.24, CI 1.127-9.356, P = 0.04). Significant association was found with risk of acute MI in recipients who possessed homozygous 59029-A allele (OR 1.47, CI 1.03-2.09, P = 0.03). While CX3CR1-I249 and M280 were found to be protective in MI patients with OR 0.46, CI 0.32-0.66, P < 0.0001 and OR 0.36, CI 0.24-0.55, P < 0.0001, respectively. It might be possible that risk of acute MI is associated with genetic variation in chemokine receptors, i.e., CCR5 and CX3CR1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744265     DOI: 10.1007/s11033-011-1031-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

Authors:  D H McDermott; J P Halcox; W H Schenke; M A Waclawiw; M N Merrell; N Epstein; A A Quyyumi; P M Murphy
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

2.  Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4.

Authors:  B Shieh; Y E Liau; P S Hsieh; Y P Yan; S T Wang; C Li
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

3.  Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.

Authors:  S Hummel; D Schmidt; B Kremeyer; B Herrmann; M Oppermann
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

Review 4.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

5.  Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.

Authors:  Alexander Niessner; Rodrig Marculescu; Arvand Haschemi; Georg Endler; Gerlinde Zorn; Cornelia M Weyand; Gerald Maurer; Christine Mannhalter; Johann Wojta; Oswald Wagner; Kurt Huber
Journal:  Thromb Haemost       Date:  2005-05       Impact factor: 5.249

6.  Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.

Authors:  Stavros Apostolakis; Stavroula Baritaki; Georgios E Kochiadakis; Nikolaos E Igoumenidis; Dimitrios Panutsopulos; Demetrios A Spandidos
Journal:  Thromb Res       Date:  2006-02-09       Impact factor: 3.944

7.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

8.  Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.

Authors:  B A Nassar; A A Nanji; T P Ransom; K Rockwood; S A Kirkland; K Macpherson; P W Connelly; D E Johnstone; B J O'Neill; I R Bata; P Andreou; L M Title
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

9.  CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

Authors:  D H McDermott; P A Zimmerman; F Guignard; C A Kleeberger; S F Leitman; P M Murphy
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.

Authors:  Eleonora Simeoni; Bernhard R Winkelmann; Michael M Hoffmann; Sylvain Fleury; Juan Ruiz; Lukas Kappenberger; Winfried März; Giuseppe Vassalli
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

View more
  4 in total

1.  Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies.

Authors:  Zhongwen Zhang; Ju Liu; Huanjun Wang; Hongxia Wu; Xuanmei Wu; Jianjun Dong; Lin Liao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Touch of chemokines.

Authors:  Xavier Blanchet; Marcella Langer; Christian Weber; Rory R Koenen; Philipp von Hundelshausen
Journal:  Front Immunol       Date:  2012-07-12       Impact factor: 7.561

3.  Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.

Authors:  Jian Wu; Rui-Xing Yin; Quan-Zhen Lin; Tao Guo; Guang-Yuan Shi; Jia-Qi Sun; Shao-Wen Shen; Qing Li
Journal:  Dis Markers       Date:  2014-08-26       Impact factor: 3.434

4.  CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link.

Authors:  S Pucci; P Mazzarelli; M J Zonetti; T Fisco; E Bonanno; L G Spagnoli; A Mauriello
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.